In order to further confirm that β-catenin nuclear accumulation was stimulated by EGFR signal in Akt1-impaired cells, we tested the effect of Gefitinib, an inhibitor of EGFR tyrosine kinase on the β-catenin nuclear accumulation in the breast cancer cells treated with Akt1 siRNA. This evidence concerns the gene AKT1 and breast cancer.